Recordati confirmed a non-binding full takeover offer from CVC Capital Partners on March 26, 2026, valuing the company at €10.9 billion ($12.6 billion) at €52 ($60) per share126.
The offer aims to delist the Italian pharmaceutical group and is subject to due diligence, financing, and partners1.
CVC already holds a controlling stake of 46.8% in Recordati as of February15.
Recordati shares jumped up to 9% initially, trading around €48.82 to €50.45 after the announcement1356.
The news was first reported by Il Sole 24 Ore, prompting Recordati's statement13.
Sources:
1. https://whtc.com/2026/03/26/recordati-shares-jump-on-report-of-planned-full-takeover-by-cvc/
2. https://firstwordpharma.com/story/7148664
3. https://www.investing.com/news/stock-market-news/cvc-capital-partners-plans-full-takeover-of-recordati-93CH-4582245
5. https://www.trustfinance.com/blog/cvc-capital-partners-plans-full-takeover-of-recordati
6. https://www.marketscreener.com/news/recordati-shares-jump-on-report-of-planned-full-takeover-by-cvc-ce7e51dadc88f22c